AI for medical and pharmaceutical research without harm filters
For medical and pharmaceutical research teams whose prompts trigger generic harm filters. Developer-controlled AI for governed, high-context research workflows.
Medical and pharmaceutical research organizations regularly describe disease pathways, toxicology, adverse events, and intervention risks in precise language that can trip generic harm filters.
abliteration.ai supports high-context research workflows while keeping data handling private by default and governance available when teams need stricter review controls.
{
"model": "abliterated-model",
"messages": [
{
"role": "system",
"content": "You assist regulated research teams with structured analysis. Return factual, audit-friendly outputs."
},
{
"role": "user",
"content": "Draft a JSON summary template for reviewing a hypothetical adverse-event report set across multiple trial cohorts."
}
],
"temperature": 0.2
}Why research prompts trigger harm filters
Life-sciences research uses language about toxicity, disease progression, contraindications, and biological harm because those concepts are core to the work. Generic filters often see the vocabulary without the research context.
Where this fits in medical and pharma workflows
The strongest fit is internal research enablement, structured analysis, and document-heavy workflows where context matters.
Governance for regulated research teams
If your organization needs review gates, Policy Gateway can add policy ownership without depending on a vendor’s opaque thresholds.
Data handling and privacy posture
Research organizations often need to know exactly what happens to prompts containing sensitive or proprietary material.